in this issue

From the Editor

Kelly talks about stem cell research, the new SEVEN PLUS from DexCom, and the Tethys pre-diabetes risk test.

Quotable Quotes

Fingersticks

An up-close look at stem cell research.

SUM Musings

Talking with family members about their risk of diabetes.

Learning Curve

Learn about anti-CD3 therapy designed to slow or stop the progression of type 1 diabetes.

Trial Watch

Bariatric surgery for type 2 diabetes, dapagliflozin, taspoglutide, and the PREVENTKD kidney disease trial.

diaTribe Dialogue

Dr. Desmond Schatz, type 1 diabetes expert.

New Now Next

The DiabetesMine diabetes product design challenge, recent FDA approval news, SymCare’s inTouch program, CGM reimbursement, the Tour de Cure Red Rider program, and the end of the Deltec Cozmo.

Test Drive - the SEVEN PLUS

Kelly tries out the new DexCom SEVEN PLUS CGM.

Test Drive - the Tethys diabetes risk test

diaTribe friend Amy Baker writes about her experience taking the Tethys diabetes risk test.

Thinking Like a Pancreas

Gary Scheiner tells you how to integrate Glycemic Index (GI) into your eating habits.

Logbook

One woman’s journey to help find a cure.

Conference Pearls

The 2009 ATTD diabetes device meeting.

TalkBack

Send us your diabetes research or product questions at talkback@diatribe.us.